Aarkstore Enterprise Colorectal Cancer Global Clinical Trials Review, Q4, 2010

Aarkstore announce a new report "Colorectal Cancer Global Clinical Trials Review

, Q4, 2010" through its vast collection of market research report.

Summary

Colorectal Cancer Global Clinical Trials Review, Q4, 2010 provides data on the Colorectal Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Colorectal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Colorectal Cancer).

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status and trial success rate

- Review of key discontinued trials (suspended, withdrawn and terminated)

- Overview of the enrollment pattern by phase for the past decade

- Number of clinical trials segmented by key drugs

- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.

- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

- Understand the dynamics of a particular indication as a whole

- Examine the performance of the trials in terms of their status, recruitment, success rates and others

- Obtain discontinued trial information for trials across the globe

- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

For more information, please visit:

http://www.aarkstore.com/reports/Colorectal-Cancer-Global-Clinical-Trials-Review-Q4-2010-76578.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

Individual With Metastatic Colon Cancer On Account of No Screening By Physician May Have A Claim Colon Cleansing Prevents Colon Cancer Imagine Being Diagnosed With Colon Cancer Metastasis After A Doctor Assured Otherwise $2.5 Million Claim For Colon Cancer Death Of 27 Year Old After Physician Dismissed Her Complaints The Risks Faced By Individuals If Their Physicians Do Not Follow Colon Cancer Screening Standards Why You Might Not Discover You Have Colon Cancer Until It Has Metastasized $1.25 Million Settlement In Lawsuit Alleging Doctor Missed Patient's Indications Of Colon Cancer In The Light Of Recent Studies In Metastatic Colorectal Cancer Physician's Failure To Follow Colon Cancer Screening Recommendations And Malpractice Claims Physician Liable For Malpractice By Supposing Without Testing That Blood Is No Due To Colon Cancer Doctor Pays $1.25 Million When Patient Dies After Multi Year Delay In Detection Of Colon Cancer Doctor Settles For $1,250,000 For Death Of Patient From Advanced Colon Cancer Diagnosed With Metastatic Colon Cancer? Was The Delay Caused By Your Doctor?